ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

This study has been completed.
Study NCT00034346.   Last updated on December 20, 2007.   Information provided by Amgen
Please refer to this study by its ClinicalTrials.gov identifier: NCT00034346


Sponsors and Collaborators
Amgen

Investigators
Study Director:     MD     Amgen    





Links to all studies - primarily for crawlers